C12N 2770/00062
By genetic engineering
Official title: by genetic engineering
C12N2770/00062 (By genetic engineering) appears on 3 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 4
- Assignees
- 3
- Inventors
- 10
- Latest grant
- 10 May 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 2 |
| 2019 | 1 | 0 |
| 2020 | 1 | 2 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
By publication year.
Recent patents
- Biological control of cucumber green mottle mosaic virus10 May 2022US 11,326,180 B2A&L Canada Laboratories Inc.
- Biological control of cucumber green mottle mosaic virus10 Nov 2020US 10,829,780 B2A&L Canada Laboratories Inc.
- RNA virus attenuation by alteration of mutational robustness and sequence space19 Feb 2019US 10,206,994 B2Institut Pasteur
- Biological control of cucumber green mottle mosaic virus31 Dec 2020US 2020/0407745 A1A&L Canada Laboratories Inc.
- Biological control of cucumber green mottle mosaic virus19 Mar 2020US 2020/0087676 A1A&L Canada Laboratories Inc.
- Crisprs19 Jul 2018US 2018/0201921 A1Excision Biotherapeutics, Inc.
- Rna virus attenuation by alteration of mutational robustness and sequence space11 Jan 2018US 2018/0008689 A1Institut Pasteur
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.